DexCom Inc. (Nasdaq: DXCM), a medical device company in Mira Mesa that specializes in glucose-monitoring for diabetes and other ailments, got a shout out from CNBC stock enthusiast Jim Cramer.
During his “Lightning Round” on CNBC on Thursday evening, Cramer called Dexcom “one of the good ones,” adding that its stock price was in “a good situation, with a great chart, too."
The company’s share price is currently hovering around $22.20. That’s short of its all-time highs in 2006, when it briefly peaked above $25 before hitting a disastrous two-year decline. But in the past year, the company has nearly doubled its share price.
In an interview with The Wall Street Transcript on Friday, Chris Cooley, managing director at Stephens Inc., cited Dexcom as an example of the "exciting developments happening in diabetes care."